SCHEMBL10061340

SCHEMBL10061340

Cc1cc(C(F)(F)F)c[nH]1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HMBS P08397 1/20 0.43
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
MAPT P10636 1/20 0.36
KIF11 P52732 3/20 0.35
DHODH Q02127 1/20 0.35
NOTUM Q6P988 1/20 0.34
ALDH1A1 P00352 2/20 0.34
HPGD P15428 1/20 0.34
IKBKB O14920 1/20 0.32
RAPGEF4 Q8WZA2 1/20 0.32
TSHR P16473 1/20 0.32
CES2 O00748 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
NFE2L2 Q16236 1/20 0.31
XPO1 O14980 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17002554 0.77 MEN1 (0.48) MEN1KMT2AMAPTNOTUMALDH1A1
SCHEMBL891125 0.76 HMBS (0.46) HMBSNOTUMALDH1A1HPGDTSHR
SCHEMBL9224370 0.74 KDM4E (0.33) MEN1KMT2AALDH1A1HPGDTSHR
SCHEMBL28222880 0.72 TSHR (0.38) MEN1KMT2AKIF11ALDH1A1HPGD
SCHEMBL28070945 0.72 ALDH1A1 (0.33) MEN1KMT2AALDH1A1HPGDTSHR
SCHEMBL29291942 0.72 MEN1 (0.31) MEN1KMT2AALDH1A1HPGDTSHR
SCHEMBL28579313 0.72 LMNA (0.33) MEN1KMT2AALDH1A1HPGDTSHR
SCHEMBL28090101 0.72 ALDH1A1 (0.37) MEN1KMT2AALDH1A1HPGDNPC1
SCHEMBL21793221 0.72 RAF1 (0.33) MEN1KMT2AALDH1A1HPGDTSHR
SCHEMBL25651305 0.68 ALDH1A1 (0.47) MEN1KMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023109926-A1 SPIROOXINDOLE COMPOUND AND USE THEREOF IN PREPARATION OF PROTEASE INHIBITOR AS ANTIVIRAL DRUG 南京药石科技股份有限公司 2023-06-22 WO disclosed
WO-2020047360-A1 BENZIMIDAZOLE COMPOUNDS AND USE THEREOF FOR TREATING ALZHEIMER'S DISEASE OR HUNTINGTON'S DISEASE NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2020-03-05 WO disclosed
US-20190295778-A1 PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, METAL COMPLEX DYE, DYE SOLUTION, AND TERPYRIDINE COMPOUND OR ESTERIFIED PRODUCT THEREOF FUJIFILM CORPORATION (JP) 2019-09-26 US disclosed
US-9947482-B2 Photoelectric conversion element, dye-sensitized solar cell, and metal complex dye used in same FUJIFILM CORPORATION (JP) 2018-04-17 US disclosed
US-9947482-B2 Photoelectric conversion element, dye-sensitized solar cell, and metal complex dye used in same FUJIFILM CORPORATION (JP) 2018-04-17 US disclosed
CN-107619408-A A kind of aminothiazole carboxylic acid derivates and its production and use 南开大学 2018-01-23 CN disclosed
CN-104650064-B Aminothiazole carboxylic acid derivatives, and preparation method and application thereof 南开大学 2017-12-05 CN disclosed
CN-107021962-A Fungicidal azocyclic amides 杜邦公司 2017-08-08 CN disclosed
CN-106986866-A Fungicidal azocyclic amides 杜邦公司 2017-07-28 CN disclosed
US-20170117099-A1 PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, METAL COMPLEX DYE, DYE SOLUTION, AND TERPYRIDINE COMPOUND OR ESTERIFIED PRODUCT THEREOF FUJIFILM CORPORATION (JP) 2017-04-27 US disclosed
US-20170117100-A1 PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, METAL COMPLEX DYE, DYE SOLUTION, AND TERPYRIDINE COMPOUND OR ESTERIFIED PRODUCT THEREOF FUJIFILM CORPORATION (JP) 2017-04-27 US disclosed
CN-104478805-B Fungicidal azacyclic amides 杜邦公司 2017-04-12 CN disclosed
US-20160042875-A1 PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, AND METAL COMPLEX DYE USED IN SAME FUJIFILM CORPORATION (JP) 2016-02-11 US disclosed
US-20160042875-A1 PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, AND METAL COMPLEX DYE USED IN SAME FUJIFILM CORPORATION (JP) 2016-02-11 US disclosed
US-20150248969-A1 PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, METAL COMPLEX DYE, DYE SOLUTION, DYE-ADSORBED ELECTRODE, AND METHOD FOR PRODUCING DYE-SENSITIZED SOLAR CELL FUJIFILM CORPORATION (JP) 2015-09-03 US disclosed
US-8338600-B2 Copper-oxygen adduct complexes, and methods of making and use JUSTUS-LIEBIG-UNIVERSITAT GIESSEN (DE) 2012-12-25 US disclosed
US-20120016127-A1 COPPER-OXYGEN ADDUCT COMPLEXES JUSTUS-LIEBIG-UNIVERSITAET GIESSEN (DE) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150248969-A1 PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, METAL COMPLEX DYE, DYE SOLUTION, DYE-ADSORBED ELECTRODE, AND METHOD FOR PRODUCING DYE-SENSITIZED SOLAR CELL CHRM1, L1CAM, CRY1 HMBS 2711/4885MEN1 144/4885KMT2A 2941/4885
US-20190295778-A1 PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, METAL COMPLEX DYE, DYE SOLUTION, AND TERPYRIDINE COMPOUND OR ESTERIFIED PRODUCT THEREOF LEF1, MLLT3, CRY1 HMBS 1117/4885MEN1 384/4885KMT2A 1248/4885
US-20120016127-A1 COPPER-OXYGEN ADDUCT COMPLEXES AOC2, AOC3, AOC1 HMBS 1431/4885MEN1 4504/4885KMT2A 4245/4885
US-20160042875-A1 PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, AND METAL COMPLEX DYE USED IN SAME CRY1, L1CAM, DLK1 HMBS 3584/4885MEN1 495/4885KMT2A 2923/4885
US-20170117100-A1 PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, METAL COMPLEX DYE, DYE SOLUTION, AND TERPYRIDINE COMPOUND OR ESTERIFIED PRODUCT THEREOF DLK1, CACNA1C, CRY1 HMBS 1351/4885MEN1 706/4885KMT2A 1617/4885
US-20170117099-A1 PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, METAL COMPLEX DYE, DYE SOLUTION, AND TERPYRIDINE COMPOUND OR ESTERIFIED PRODUCT THEREOF LEF1, MLLT3, CRY1 HMBS 1117/4885MEN1 384/4885KMT2A 1248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.